Investigating a role for Protein Kinase D1 (PRKD1) in adipose tissue browning

MKA Crowder - 2023 - ir.vanderbilt.edu
Brown adipose tissue (BAT) has in recent times been rediscovered in adult humans, and
together with work from preclinical models, shown to have the potential of providing a variety …

Antidiabetic drugs as the future of obesity treatment

A Kuzio, A Cieplińska, K Ziojła-Lisowska - Quality in Sport, 2024 - apcz.umk.pl
Obesity is a multifactorial chronic disease with complex pathogenesis. Its causes are
considered to be genetic, biological, epigenetic, environmental, developmental and …

Obesity: Is the tide turning?

T Heffernan - 2023 - repository.rcsi.com
The treatment of obesity has repeatedly been hindered by failure to create an effective anti-
obesity medication. Meanwhile, the obesity epidemic has continued to worsen. In recent …

Tirzepatide: O Início de uma Nova Era na Terapêutica da Diabetes

A Raimundo - Medicina Interna, 2023 - revista.spmi.pt
A prevalência da obesidade e consequentemente da diabetes tem vindo a aumentar de
forma exponencial nas últimas décadas, prevendo-se uma manutenção desta tendência …

Peripheral neuropathy significantly increases the risk of persistent lower extremity ulcers in individuals with diabetes in the United States: a cross-sectional study …

Z Li, Z Wei - 2024 - researchsquare.com
Background Lower extremity ulcers are a major health concern in the diabetic population as
they can result in chronic wounds, infection, and amputation. Previous studies have shown …

[PDF][PDF] Pharmacotherapeutics efficacy in obesity treatment: A systematic review

BA Tarboush, HF Karali, MT Zaigham… - International Journal of …, 2023 - comedjournal.com
Introduction: Obesity is a public health concern on a global scale, obesity can lead to
significant risk of developing various comorbidities. Lifestyle interventions along with …

[PDF][PDF] Tizerpatida: a nova promessa contra a obesidade Tizerpatide: the new promise against obesity Tizerpatida: la nueva promesa contra la obesidad

GML de Carvalho, LAS Barros - Brazilian Journal of Health …, 2024 - scholar.archive.org
La obesidad es una enfermedad crónica y progresiva caracterizada por la acumulación
excesiva de grasa corporal, que puede conllevar diversos riesgos para la salud. Afecta a …

[PDF][PDF] Flavonoids and Nanotechnology in Insulin Resistance Diabetic Complications

S Kumar, M Singh, PS Murkute, A Chakraborty, A Farid… - researchgate.net
Diabetes is a persistent metabolic disorder characterized by elevated blood sugar levels,
potentially leading to complications such as diabetic retinopathy, neuropathy, and …

[PDF][PDF] Onwards and Upwards: Navigating the Future of Diabetes Care.

M Maladkar - The Indian Practitioner, 2023 - researchgate.net
The escalating global prevalence of type 2 diabetes mellitus prompts a critical need for
innovative approaches to its management. Managing T2DM presents challenges, and the …

Evaluación positiva de medicamentos: julio, septiembre y octubre de 2022

A García-Luque, MA Silva-Cuevas… - Sanidad …, 2022 - SciELO Espana
Se reseñan los medicamentos evaluados y con dictamen positivo por comisión de expertos
de la Agencia Europea del Medicamento, hechos públicos en julio, septiembre y octubre de …